基本信息
浏览量:4
职业迁徙
个人简介
Charlotte is a Research Associate on the Rare2030 project and joined Imperial College Business School in 2019. The aim of the Rare2030 project, which is co-funded by the European Union Pilot Projects and Preparatory Actions Programme, is to propose policy recommendations to guide future European policy on rare diseases by using a participatory foresight approach and additional innovative consensus building methods. As part of this project, Charlotte investigates the R&D pipeline and the successful market launch of orphan drugs.
Charlotte completed her PhD in Medicine on n-of-one trials for rare diseases at VU University in Amsterdam, using rare neuromuscular diseases as a case study. Her dissertation examined the contribution that n-of-one trials can make to the creation of an evidence base for treatments for patients with rare diseases. In addition to conducting two clinical trials using the n-of-one methodology, she also examined the acceptability of evidence from series of n-of-one trials to healthcare regulators and HTA agencies (i.e. the Dutch National Health Care Institute and the Dutch national competent authority for market approval of medicines, the Medicines Evaluation Board).
Before joining Imperial College, Charlotte worked as a Research Psychologist at the Department of Behavioural Science and Health at University College London. There, she examined the prevalence and sociodemographic distribution of cancer fear in the general population, and its association with uptake of cancer screening. Charlotte holds degrees in Medicine (PhD), Psychology (BSc), and Philosophy (BA) and is an Associate Fellow of the Higher Education Academy (AFHEA).
Charlotte completed her PhD in Medicine on n-of-one trials for rare diseases at VU University in Amsterdam, using rare neuromuscular diseases as a case study. Her dissertation examined the contribution that n-of-one trials can make to the creation of an evidence base for treatments for patients with rare diseases. In addition to conducting two clinical trials using the n-of-one methodology, she also examined the acceptability of evidence from series of n-of-one trials to healthcare regulators and HTA agencies (i.e. the Dutch National Health Care Institute and the Dutch national competent authority for market approval of medicines, the Medicines Evaluation Board).
Before joining Imperial College, Charlotte worked as a Research Psychologist at the Department of Behavioural Science and Health at University College London. There, she examined the prevalence and sociodemographic distribution of cancer fear in the general population, and its association with uptake of cancer screening. Charlotte holds degrees in Medicine (PhD), Psychology (BSc), and Philosophy (BA) and is an Associate Fellow of the Higher Education Academy (AFHEA).
研究兴趣
论文共 64 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Charan Bijlani,Charlotte Vrinten,Cornelia Junghans,Kiara Chang, Ellie Lewis, UmmeZeinab Mulla,Paraskevi Seferidi, Anthony A. Laverty,Eszter P. Vamos
BMC Public Healthno. 1 (2024): 1-11
Nicholas S Hopkinson,Charlotte Vrinten,Jennie C Parnham,Márta K Radó,Filippos Filippidis,Eszter P Vamos,Anthony A Laverty
Thoraxpp.thorax-2023, (2024)
medRxiv (Cold Spring Harbor Laboratory) (2023)
引用1浏览0引用
1
0
medRxiv (Cold Spring Harbor Laboratory) (2023): 91-91
SSM Annual Scientific Meeting (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn